Stockholm Stock Exchange | Mid Cap
3 months
Pareto SecuritiesCarnegieBryan GarnierNordea MarketsDNBJefferiesHandelsbankenDNB Markets

Price Targets For Camurus

AnalystPrice TargetDateUpside
Pareto Securities332 SEKMay 25
Carnegie315 SEKMay 3
Bryan Garnier320 SEKFeb 14
Nordea Markets305 SEKNov -22
DNB310 SEKSep -22
Jefferies205 SEKApr -22
Handelsbanken235 SEKDec -21
DNB Markets275 SEKNov -21

About The Company

Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases.